Vancouver, January 28, 2020 – Burcon NutraScience Corporation (the “Company” or “Burcon”) (TSX:BU) is pleased to announce that it has entered into an agreement with a syndicate of underwriters co-led by Canaccord Genuity Corp. and Beacon Securities Limited (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to…
Vancouver, British Columbia, January 24, 2020 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to announce today that Burcon, Nestlé and Merit Functional Foods Corporation (“Merit”) have entered into a joint development agreement to tailor Burcon and Merit’s novel plant-based proteins for use in Nestlé…
Vancouver, British Columbia, January 10, 2020 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to share that its joint venture company, Merit Functional Foods Corporation (“Merit Foods”) announced today that it has received a significant co-investment from Protein Industries Canada, which will help facilitate the…
Vancouver, British Columbia, December 10, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce that it has closed its previously announced non-brokered private placement (see news releases of the Company dated November 25, 2019 and November 28, 2019) of…
Vancouver, British Columbia, November 28, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce that, based on orders received, it has increased its previously announced non-brokered private placement (see news release of the Company dated November 25, 2019) of…
Vancouver, British Columbia, November 25, 2019 — Burcon NutraScience Corporation (TSX: BU) (“Burcon” or the “Company”), a global technology leader in the development of plant-based proteins, is pleased to announce a non-brokered private placement of convertible debentures (the “Convertible Debentures”) for an aggregate principal amount of up to $4 million (the “Offering”). Insiders of the…
Vancouver, British Columbia, October 21, 2019 — Burcon NutraScience Corporation (TSX: BU), a global technology leader in the development of plant-based proteins, is pleased to announce today that the US Food and Drug Administration (“FDA”) has issued a GRAS (Generally Recognized As Safe) no-objection letter for Peazazz® and Peazac® pea proteins. The “Letter of No…